Cargando…
PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective
Positron emission tomography with selective radioligands advances the drug discovery and development process by revealing information about target engagement, proof of mechanism, pharmacokinetic and pharmacodynamic profiles. Positron emission tomography (PET) is an essential and highly significant t...
Autores principales: | Nerella, Sridhar Goud, Singh, Priti, Sanam, Tulja, Digwal, Chander Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919964/ https://www.ncbi.nlm.nih.gov/pubmed/35295604 http://dx.doi.org/10.3389/fmed.2022.812270 |
Ejemplares similares
-
Editorial: Development of selective carbon-11 radioligands for target-based PET molecular imaging in oncology, cardiology and neurology
por: Nerella, Sridhar Goud, et al.
Publicado: (2023) -
ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2022) -
Editorial: Case reports in PET imaging
por: Taralli, Silvia, et al.
Publicado: (2022) -
Interest of Pet Imaging in Multiple Myeloma
por: Jamet, Bastien, et al.
Publicado: (2019) -
Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014)